Answer
Kidney impairment increases migalastat exposure. The product is not recommended when estimated GFR is below 30 mL/min/1.73 m².
Sources for this answer
- Galafold 123 mg hard capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.